Figure 3
From: Early life neonicotinoid exposure results in proximal benefits and ultimate carryover effects
(a) Residuals of Scaled Lean Mass Index (day 800) split by sex and early-life treatments (Control in blue and Imidacloprid in orange). Control (n = 20) = Ad libitum-Control + Restricted-Control / Imidacloprid (n = 16) = Ad libitum-Imidacloprid + Restricted-Imidacloprid). (b) Lean mass corrected Basal Metabolic Rate (model residuals) (day 800) according to the sex and the two treatments (Control and Imidacloprid). Specifications of the boxplots are provided in the caption of Figure 1. These results show individuals treated during the first half of the experiment. P-value \(\le\) 0.05*.
